{
    "clinical_study": {
        "@rank": "60592", 
        "brief_summary": {
            "textblock": "Peripheral blood mononuclear cells (PBMC) will be collected from patients who have leukemia\n      or lymphoma or other medical conditions involving altered lymphohematopoietic stem cell or\n      immunological function.  These PBMC will be assessed for cellular markers by flow cytometry\n      and will be studied for in vitro T helper, effector and suppressor cell functions, to\n      determine whether cell mediated immunity is involved in the condition, or indicative of\n      therapeutic efficacy or is predictive for outcome.  Peripheral blood stem cells (PBSC) from\n      untreated donors and from cytokine treated donors will be assessed for cellular markers and\n      in vitro growth characteristics that might be useful for identifying normal stem cell\n      populations."
        }, 
        "brief_title": "In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients", 
        "completion_date": "February 2003", 
        "condition": [
            "Immunologic Deficiency Syndrome", 
            "Leukemia", 
            "Lymphoma", 
            "Neoplasm"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Immunologic Deficiency Syndromes", 
                "Leukemia", 
                "Lymphoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "Peripheral blood mononuclear cells (PBMC) and mobilized peripheral blood stem cells (PBSC)\n      will be collected from patients who have leukemia or lymphoma or other medical conditions\n      involving altered lymphohematopoietic stem cell or immunological function.  These PBMC will\n      be assessed for cellular markers by flow cytometry and will be studied for in vitro T\n      helper, effector and suppressor cell functions, to determine whether cell mediated immunity\n      is involved in the condition, or indicative of therapeutic efficacy or is predictive for\n      outcome.  PBSC will be assessed for cellular markers and in vitro growth characteristics\n      that might be useful for identifying normal stem cell populations.  Furthermore the capacity\n      of stem cells to reconstitute the T lymphocyte lineage will be assessed using ex vivo\n      explant cultures established with thymic or secondary lymphoid tissues."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Patients obtained from collaborators within and outside the NCI."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "1000", 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001336", 
            "org_study_id": "930129", 
            "secondary_id": "93-C-0129"
        }, 
        "keyword": [
            "Transplantation", 
            "Cancer", 
            "Cellular Immunity", 
            "Stem Cell Function", 
            "Immunodeficiency"
        ], 
        "lastchanged_date": "March 3, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Cancer Institute (NCI)"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001336"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 1993", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "February 2003"
    }, 
    "geocoordinates": {
        "National Cancer Institute (NCI)": "38.985 -77.095"
    }
}